Markets rally amid COVID-19 vaccine

09:50, 16 December 2020

Optimism prevailed on the global markets - Tuesday Review, December 15

COVID-19 vaccine rollout in the US and Brexit talks got the markets going up

The USA

The markets cheered the COVID-19 vaccine rollout and closed in the green territory. USA30 gained 1.13%, while USA500 went up 1.29%. TECH100 added 1.25%.

Gold was up 1.39% to $1,857.55 per ounce.

Crude oil rose 1.19%, reaching $47.55 a barrel.

The Dollar Index lost 0.31% and traded at 90.373.

Asia and Australia

The benchmarks traded lower on Tuesday amid tighter COVID-19 restrictions.

HongKong45 fell 0.76%.

Japan225 lost 0.20%.

Down under, Australia200 slipped 0.26% after China banned imports of Australian coal.

USD/JPY closed 0.40% lower at 103.61.

Europe

The rising number of COVID-19 infections was put aside as the markets focused on the ongoing Brexit negotiations. Germany30 closed 1.06% higher, while France40 added 0.6%. UK100 climbed 0.3%.

Brent oil added 0.82% to trade at $50.70 a barrel.

EUR/USD traded at 1.2160 after it gained 0.14%.

Sources: investing.com, marketwatch.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.